ESPERION THERAPEUTICS INC NE filings

SEC filings by ESPERION THERAPEUTICS INC NE (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2024-02-14Point72 Asset Management, L.P.Esperion Therapeutics, Inc.4,8000.2%EDGAR
SC 13G/A2024-02-14CVI Investments, Inc.Esperion Therapeutics, Inc.00.0%EDGAR
SC 13G/A2024-02-14Deep Track Capital, LPEsperion Therapeutics, Inc.00.0%EDGAR
SC 13G/A2024-02-14Two Seas Capital LPEsperion Therapeutics, Inc.7,686,1206.8%EDGAR
SC 13G/A2024-02-13VANGUARD GROUP INCEsperion Therapeutics, Inc.5,137,7504.5%EDGAR
SC 13G/A2024-02-09WASATCH ADVISORS LPEsperion Therapeutics, Inc.--EDGAR
SC 13G/A2024-01-24BB BIOTECH AGEsperion Therapeutics, Inc.4,194,0643.7%EDGAR
SC 13G/A2024-01-24BB BIOTECH AGEsperion Therapeutics, Inc.9,194,0645.1%EDGAR
SC 13G/A2024-01-17MILLENNIUM MANAGEMENT LLCEsperion Therapeutics, Inc.3,643,9513.2%EDGAR
SC 13G/A2024-01-03Meditor Group LtdEsperion Therapeutics, Inc.3,791,3003.3%EDGAR
SC 13G2023-10-05Two Seas Capital LPEsperion Therapeutics, Inc.7,922,1707.4%EDGAR
SC 13G2023-08-29MILLENNIUM MANAGEMENT LLCEsperion Therapeutics, Inc.5,366,4525.0%EDGAR
SC 13G2023-08-28MILLENNIUM MANAGEMENT LLCEsperion Therapeutics, Inc.5,223,4394.9%EDGAR
SC 13G/A2023-06-08BlackRock Inc.Esperion Therapeutics, Inc.4,645,3594.9%EDGAR
SC 13G2023-04-05Point72 Asset Management, L.P.Esperion Therapeutics, Inc.4,314,2864.8%EDGAR
SC 13G/A2023-02-14Point72 Asset Management, L.P.Esperion Therapeutics, Inc.2,277,0004.0%EDGAR
SC 13G/A2023-02-14CVI Investments, Inc.Esperion Therapeutics, Inc.5,500,0006.9%EDGAR
SC 13G/A2023-02-14BB BIOTECH AGEsperion Therapeutics, Inc.4,194,0645.7%EDGAR
SC 13G/A2023-02-10WASATCH ADVISORS INCEsperion Therapeutics, Inc.--EDGAR
SC 13G/A2023-02-09VANGUARD GROUP INCEsperion Therapeutics, Inc.4,260,4645.8%EDGAR